Vera Therapeutics Wins FDA Approval for TRUTAKNA in IgAN
BRISBANE, Calif., July 7, 2026 Vera Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
AI drug discovery artificial intelligence ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology Immuno-Oncology immunology Immunotherapy Medical Device Medical Devices Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine targeted therapy
BRISBANE, Calif., July 7, 2026 Vera Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has...
MAPLE GROVE, Minn., July 7, 2026 Francis Medical has announced that Orange County Urology Associates (OCUA) has become the...
BEVERLY, Mass., July 7, 2026 Akston Biosciences Corporation has announced encouraging preclinical data demonstrating that its investigational NGF-targeting Ambifect®...
ALAMEDA, Calif., July 7, 2026 Penumbra, Inc., a global leader in thrombectomy technologies, has announced the first patient enrollment...
ALAMEDA, Calif., June 11, 2026 Penumbra, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance...
Alameda, California | April 13, 2026 Penumbra, Inc. has announced compelling 90-day results from the STORM-PE randomized controlled trial,...
